Hepatitis B News

• GICS 2022 Adding TACE to Lenvatinib Improves Survival in Liver Cancer Transarterial chemoembolization (TACE) added onto lenvatinib is a new first-line option for patients with advanced liver cancer, say LAUNCH trialists.
  Medscape Medical News, January 25, 2022
• Higher Corticosteroid Dose Tied to HBV Reactivation in People With Resolved Infection In people with resolved hepatitis B virus infection, exposure to higher doses of corticosteroids is associated with an increased risk of HBV reactivation and hepatitis flare, according to researchers in China.
  Reuters Health Information, January 20, 2022
• HCC Prevention Should Target Patients With Moderate Fibrosis Efforts to prevent hepatocellular carcinoma unrelated to hepatitis or cirrhosis should be focused on individuals with an intermediate degree of liver fibrosis, suggests a large-scale data analysis.
  First Look, December 20, 2021
• USCHA 2021 New Hepatitis B Vaccination Recommendations Praised With hepatitis B vaccination rates low and infection rates rising, experts hope the new recommendations will raise clinician awareness and simplify screening.
  Medscape Medical News, December 16, 2021
• AASLD 2021 Bulevirtide Shows Real-World Efficacy Versus HDV French program reveals good cure rates but also a high rate of modifications or discontinuations.
  Medscape Medical News, December 10, 2021
• AASLD 2021 Be Cautious With HBV Drug Withdrawal More than half of chronic hepatitis B e antigen–negative patients who withdraw from nucleoside or nucleotide analogue therapy experienced relapse within 4 years.
  Medscape Medical News, December 01, 2021
• Booster Counteracts Waning Immunity of Initial Pfizer Doses A large study shows that the chances of becoming infected with SARS-CoV-2 in the first 2 months after the Pfizer booster drop an estimated 86% compared with having only the two primary shots.
  Medscape Medical News, December 01, 2021
• From Cows to COVID: The Spooky Origins of Vaccines Like many life-saving innovations in medicine, vaccination emerged long before we understood how it worked.
  Undark, November 12, 2021
• ACIP Recommends Universal HBV Vaccination for Adults Under 60 Will the universal recommendation help reinvigorate stalling declines in hepatitis B infections over the past decade?
  Medscape Medical News, November 04, 2021
• Novel Blood-Based Panel Highly Effective for Early-Stage HCC A test like this could help enhance guideline-recommended surveillance methods used for at-risk patients.
  Medscape Medical News, November 04, 2021
• Liver Disease Linked to Higher Rate of Cardiovascular Disease Liver disease was linked to a doubling of risk for cardiovascular disease compared with no liver disease in observational data.
  First Look, November 02, 2021
• ECTRIMS 2021 MS and (Non-COVID) Vaccinations: Consensus Recommendations The first European consensus on vaccination in patients with MS has been developed by the European Committee for Treatment and Research in Multiple Sclerosis and the European Academy of Neurology.
  Medscape Medical News, October 18, 2021
• The Evolution of HBV, From Hunter-Gatherers to Today The prehistoric origins of hepatitis B virus are painted in new color by this study analyzing the largest ever dataset of ancient viral genomes.
  Quick Take, October 08, 2021
• NAMS 2021 Updates to CDC's STI Guidelines Relevant to Midlife Women Too Rates of chlamydia and gonorrhea among women older than 35 have steadily increased over the past decade, and syphilis rates have climbed steeply, data show.
  Medscape Medical News, September 28, 2021
• SPD 2021 Hep B Vaccine Response Varies in Some Pediatric Patients Although the vaccine series provides protection in most healthy individuals, a decreased response has been noted in some pediatric patients, including those with inflammatory and autoimmune diseases.
  Medscape Medical News, August 13, 2021
• Clinical Practice Guideline: Vaccination in Patients With IBD The two-part clinical practice guideline covers both live and inactivated vaccines for adult and pediatric patients who have irritable bowel disease (IBD).
  Medscape Medical News, August 12, 2021
• HBV Screen Often Incomplete Before Tocilizumab, Tofacitinib Used About three quarters of patients starting either drug in a single health system did not undergo complete hepatitis B virus screening beforehand.
  Medscape Medical News, August 10, 2021
• New Guideline for Replacement ART: CAB/RPV LA Not for Everyone The New York State Department of Health AIDS Institute's CAB/RPV guidelines highlight important clinical and patient considerations for injectable antiretroviral therapy.
  Medscape Medical News, August 02, 2021
• New Antiviral Drug Promising Against HBV A hepatitis B virus core protein allosteric modulator appears safe and shows antiviral action in patients with chronic HBV infection, according to a small company-funded study.
  Reuters Health Information, July 20, 2021
• ILC 2021 Protein Expression May Predict HBV DNA Suppression Protein expression patterns after treatment for HBV infections may help clinicians refine therapy.
  Medscape Medical News, July 08, 2021